| 000 | 01234 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516024245.0 | ||
| 264 | 0 | _c20111024 | |
| 008 | 201110s 0 0 eng d | ||
| 022 | _a1873-2402 | ||
| 024 | 7 |
_a10.1016/j.biopsych.2011.01.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarch, Deanna M | |
| 245 | 0 | 0 |
_aUsing brain imaging measures in studies of procognitive pharmacologic agents in schizophrenia: psychometric and quality assurance considerations. _h[electronic resource] |
| 260 |
_bBiological psychiatry _cJul 2011 |
||
| 300 |
_a13-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aBrain Mapping _xmethods |
| 650 | 0 | 4 |
_aCognition Disorders _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNootropic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aPsychometrics _xmethods |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aResearch Design _xstandards |
| 650 | 0 | 4 |
_aSchizophrenia _xcomplications |
| 700 | 1 | _aMathalon, Daniel H | |
| 773 | 0 |
_tBiological psychiatry _gvol. 70 _gno. 1 _gp. 13-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopsych.2011.01.004 _zAvailable from publisher's website |
| 999 |
_c20611167 _d20611167 |
||